Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven® use;Hémorragie de la délivrance « menaçant la vie » et utilisation du facteur VII recombinant activé rFVIIa NovoSeven®

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 36, Issue 1, 2007, Pages 78-82

  Courtois, L ^a   Becher, P ^a   Miot, S ^a   Maisonnette Escot, Y ^a   Sautiere J L ^a   Berthier, F ^b   Samain, E ^b   Maillet, R ^a   Riethmuller, D ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Postpartum haemorrhage; Recombinant activated factor VII

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPOVOLEMIC SHOCK; POSTPARTUM HEMORRHAGE; SEPSIS; THROMBOSIS; HEMORRHAGIC SHOCK; HEMOSTASIS; MULTIMODALITY CANCER THERAPY; PREGNANCY; TREATMENT OUTCOME; VASCULAR SURGERY;

ADULT; COAGULANTS; COMBINED MODALITY THERAPY; FACTOR VII; FEMALE; HEMOSTASIS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RECOMBINANT PROTEINS; SHOCK, HEMORRHAGIC; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 34247194620     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgyn.2006.09.002     Document Type: Article

References (22)

1. Subtil D., Sommé A., Ardiet E., and Depret-Mosser S. Hémorragies du post-partum : fréquence, conséquences en termes de santé et facteurs de risque avant l'accouchement. J. Gynecol. Obstet. Biol. Reprod. 33 (2004) 4S9-4S16
2. Dreyfus M., Beucher G., Mignon A., and Langer B. Prise en charge obstétricale initiale en cas d'hémorragie du post-partum. J. Gynecol. Obstet. Biol. Reprod. 33 (2004) 4S57-4S64
3. Langer B., Boudier E., Haberstich R., and Dreyfus M. Prise en charge obstétricale en cas d'hémorragie du post-partum qui persiste malgré les mesures initiales ou qui est grave d'emblée. J. Gynecol. Obstet. Biol. Reprod. 33 (2004) 4S73-4S79
4. D'Ercole C., Shojai R., Desbriere R., Cravello L., and Boubli L. Hémorragies du post-partum immédiat : techniques et indications de la chirurgie. J. Gynecol. Obstet. Biol. Reprod. 33 (2004) 4S103-4S119
5. Pelage J.P., and Laissy J.P. Prise en charge des hémorragies graves du post-partum : indications et techniques de l'embolisation artérielle. J. Gynecol. Obstet. Biol. Reprod. 33 (2004) 4S93-4S102
6. Mayo A., Misgav M., Kluger Y., Geenberg R., Pauzner D., Klausner J., et al. Recombinant activated factor VII (Novoseven™): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding. Vox Sang. 87 (2004) 34-40
7. Brice A., Hilbert U., Roger-Christoph S., Fernandez H., Dumenil A.S., Descorps-Declère A., et al. Intérêt du facteur VII activé recombinant dans l'hémorragie de la délivrance sévère réfractaire à la prise en charge conservatrice conventionnelle. Ann. Fr. Anesth. Reanim. 23 (2004) 1084-1088
8. Ahonen J., and Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br. J. Anaesth. 94 (2005) 592-595
9. Price G., Kaplan J., and Skowronski G. Use of recombinant factor VIIa to treat life-threatening non-surgical bleeding in a post-partum patient. Br. J. Anaesth. 93 (2004) 298-300
10. Boehlen F., Morales M.A., Fontana P., Ricou B., Irion O., and de Moerloose P. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. BJOG 111 (2004) 284-287
11. Dutton R.P., Hess J.R., and Scalea T.M. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J. Clin. Anesth. 15 (2003) 184-188
12. Martinowitz U., Kenet G., Lubetski A., Luboshitz J., and Segal E. Possible role of recombinant activated factor VII (rFVIIa) in the control of haemorrhage associated with massive trauma. Can. J. Anaesth. 49 (2002) S15-S20
13. Friederich P.W., Christiaan P.H., Embert J.M., Geerdink M.G., Keller T., Kurth K.H., et al. Effects of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled study. Lancet 361 (2003) 201-205
14. Bouwmeester F.W., Jonkhoff A.R., Verheijen R.H., and van Geijn H.P. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet. Gynecol. 101 (2003) 1174-1176
15. Segal S., Shemesh I.Y., Blumenthal R., Yoffe B., Laufer N., Ezra Y., et al. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch. Gynecol. Obstet. 268 (2003) 266-267
16. Boffard K.D., Riou B., Warren B., Choong P.I., Rizoli S., Rossaint R., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J. Trauma 59 (2005) 8-15
17. Diprose P., Herbertson M.J., O'Shaughnessy D., and Gill R.S. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br. J. Anaesth. 95 (2005) 596-602
18. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 352 (2005) 777-785
19. Raobaikady R., Redman J., Ball J.A., Maloney G., and Grounds R.M. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. Br. J. Anaesth. 94 (2005) 586-591
20. Lodge J.P., Jonas S., Oussoultzoglou E., Malago M., Jayr C., Cherqui D., et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 102 (2005) 269-275
21. Vincent J.L., Rossaint R., Riou B., Ozier Y., Zideman D., and Spahn D.R. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding-a European perspective. Crit. Care 10 (2006) R120
22. Martinowitz U., and Michaelson M on behalf of the Israeli Multidisciplinary rFVIIa Task Force. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J. Thromb. Haemost. 3 (2005) 640-648